When Alexis Cholas lost his right arm as a volunteer combat medic near the front lines in eastern Ukraine, his civilian career as a surgeon was over. Thanks to a new bionic arm, he was able to continue working in healthcare and is now a rehab specialist helping other amputees.
The 26-year-old is delighted with his sleek black robotic arm — he described it as “love at first sight” — and realizes how lucky he was to get one.
“There are fewer [bionic] arms available than lost ones,” Cholas said.
Photo: AP
Russia’s invasion of Ukraine has created a massive need for prosthetic limbs. An estimated 20,000 Ukrainians have had amputations since the war started in February last year, many of them soldiers who lost arms or legs due to blast wounds.
Only a small number was able to receive bionic prostheses, which are more advanced and can provide greater mobility than the traditional prosthetic limbs.
They are also far more costly than conventional prostheses.
Bionic artificial limbs typically pick up electrical signals from the muscles that remain above the amputation site, thanks to something called myoelectric technology, to carry out an intended motion.
Cholas’ bionic arm was made by Esper Bionics. Before last year, the Ukrainian start-up primarily targeted the US market, but due to the sharp rise in demand for prosthetic limbs caused by the war, Esper now distributes 70 percent of its products at home.
The company’s production hub in the capital, Kyiv, is working at full capacity, with more than 30 workers producing about dozen bionic hands a month.
In one corner of the factory, a small group of engineers huddle as they program, assemble and test the elegant bionic arms — known as Esper Hand. Each finger’s movement on the robotic hand is accompanied by a soft whirring sound, assuring the engineers of its smooth operation.
Bohdan Diorditsa, head of strategic relations at the company, said that despite ramping up production, Esper Bionics is struggling to keep up with demand, with almost 120 people on the waitlist.
In Ukraine, the company said it provides the bionic prostheses at zero profit for about US$7,000 a piece, just enough to cover production costs.
In the US, the Esper Hand sells for more than US$20,000.
“We do not consider Ukraine as a market, but rather as an opportunity to help,” Diorditsa said.
Compared to a conventional prosthesis, which is designed to replicate simple basic functions of a missing arm or leg, a bionic one offers the capability to restore fine motor skills.
“Everyone wants them,” said Anton Haidash, a prosthetist at Unbroken, a municipal center in Lviv that focuses on rehabilitation of civilians and soldiers affected by the war.
The center has helped provide prosthetic limbs to about 250 people so far, including about 20 bionic arms.
The difference in cost is significant. While bionic limbs can cost up to US$50,000, conventional artificial limbs are priced at US$800 to US$2,700, Haidash said.
Ukrainians can get the regular artificial limbs free of charge through the public health care system. To get a bionic prosthesis, they normally need additional funding from charities or rehabilitation centers such as Unbroken, which depend on donations.
While patients can make the final decision about the type of prostheses they want, a variety of factors, including the nature of the injury and the person’s occupation, also play a role.
Unbroken purchases bionic prostheses from German and Icelandic companies as well as Esper Bionics, whose notable advantage is having a manufacturing and a service center in Ukraine. This means people do not need to travel abroad when a repair or resizing is required.
Another outstanding characteristic of the Esper Hand, which is powered by artificial intelligence (AI), is its ability to adapt over time, learning the user’s unique interactions with the hand.
After getting outfitted with his bionic arm, Cholas went back to volunteering as a combat medic on the front lines, while in his day job in Kyiv he works as a rehabilitation specialist in a public hospital. Most of his patients are members of the military or civilians who, like him, have lost limbs.
He said that their shared experience helps him quickly develop a rapport with his patients.
“I now know a lot not only from textbooks, but also from my own experience,” he said.
Cholas speaks to his patients encouragingly as he examines their injuries. His movements with the bionic hand are natural and fluid. He effortlessly removes a bandage and dresses a patient’s wounds without the assistance of nurses.
The bionic prosthesis allows him to perform even delicate movements, such as picking up a grape without crushing it, he said.
“I feel uncomfortable when I’m without the prosthesis,” he said. “But when I have the bionic arm on, I feel comfortable. It’s like a part of you.”
GROWING OWINGS: While Luxembourg and China swapped the top three spots, the US continued to be the largest exposure for Taiwan for the 41st consecutive quarter The US remained the largest debtor nation to Taiwan’s banking sector for the 41st consecutive quarter at the end of September, after local banks’ exposure to the US market rose more than 2 percent from three months earlier, the central bank said. Exposure to the US increased to US$198.896 billion, up US$4.026 billion, or 2.07 percent, from US$194.87 billion in the previous quarter, data released by the central bank showed on Friday. Of the increase, about US$1.4 billion came from banks’ investments in securitized products and interbank loans in the US, while another US$2.6 billion stemmed from trust assets, including mutual funds,
Micron Memory Taiwan Co (台灣美光), a subsidiary of US memorychip maker Micron Technology Inc, has been granted a NT$4.7 billion (US$149.5 million) subsidy under the Ministry of Economic Affairs A+ Corporate Innovation and R&D Enhancement program, the ministry said yesterday. The US memorychip maker’s program aims to back the development of high-performance and high-bandwidth memory chips with a total budget of NT$11.75 billion, the ministry said. Aside from the government funding, Micron is to inject the remaining investment of NT$7.06 billion as the company applied to participate the government’s Global Innovation Partnership Program to deepen technology cooperation, a ministry official told the
Taiwan Semiconductor Manufacturing Co (TSMC, 台積電), the world’s leading advanced chipmaker, officially began volume production of its 2-nanometer chips in the fourth quarter of this year, according to a recent update on the company’s Web site. The low-key announcement confirms that TSMC, the go-to chipmaker for artificial intelligence (AI) hardware providers Nvidia Corp and iPhone maker Apple Inc, met its original roadmap for the next-generation technology. Production is currently centered at Fab 22 in Kaohsiung, utilizing the company’s first-generation nanosheet transistor technology. The new architecture achieves “full-node strides in performance and power consumption,” TSMC said. The company described the 2nm process as
Even as the US is embarked on a bitter rivalry with China over the deployment of artificial intelligence (AI), Chinese technology is quietly making inroads into the US market. Despite considerable geopolitical tensions, Chinese open-source AI models are winning over a growing number of programmers and companies in the US. These are different from the closed generative AI models that have become household names — ChatGPT-maker OpenAI or Google’s Gemini — whose inner workings are fiercely protected. In contrast, “open” models offered by many Chinese rivals, from Alibaba (阿里巴巴) to DeepSeek (深度求索), allow programmers to customize parts of the software to suit their
RSS